Immune cells inside glioblastoma help the tumor resist treatment
Original title: Tumor-associated macrophages in glioblastoma: implications for immunotherapy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of where the science is heading, not a new result in people.
The short version
Certain immune cells live inside glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary and help the tumor fight off treatment.
What was studied. This is a review paper. Scientists went through recent research on immune cells called macrophages that sit inside glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary tumors. They looked at how these cells get in the way of treatment.
What they found. Macrophages are the most common immune cell found inside these tumors. They come from two different places in the body, and they come in many types. The review says these cells help the tumor grow and help it resist temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary chemotherapy. They also help it resist immune treatments, including CAR T cell therapy. glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary is hard to treat, and people with it often live about 15 months even with surgery, radiation, and temozolomide.
What this means, and what it doesn't
What it could mean: Nothing about care today changes because of this paper. It points to these immune cells as a target for future drugs. Ideas being looked at include removing these cells, changing how they act, or using tiny particles to carry drugs into the brain. The authors hope this helps scientists plan better trials.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is a review of other people's research, not a new test in patients. None of the ideas in it have been shown to help people live longer. Most of this work is still in the lab. Ask your own care team about your treatment plan.
Source: PubMed, October 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.